Literature DB >> 20670721

A diagnosis in vein.

Gregory Piazza1, Marshall A Wolf, Marie Gerhard-Herman.   

Abstract

Entities:  

Mesh:

Year:  2010        PMID: 20670721      PMCID: PMC2913145          DOI: 10.1016/j.amjmed.2010.04.016

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  8 in total

Review 1.  Diagnosis and management of common compression and entrapment neuropathies.

Authors:  W W Campbell
Journal:  Neurol Clin       Date:  1997-08       Impact factor: 3.806

2.  Neurovascular compression of the common peroneal nerve by varicose veins.

Authors:  N Yamamoto; K Koyano
Journal:  Eur J Vasc Endovasc Surg       Date:  2004-09       Impact factor: 7.069

Review 3.  Peroneal neuropathy.

Authors:  B Katirji
Journal:  Neurol Clin       Date:  1999-08       Impact factor: 3.806

Review 4.  Management of symptomatic and asymptomatic popliteal venous aneurysms: a retrospective analysis of 25 patients and review of the literature.

Authors:  C Sessa; P Nicolini; M Perrin; I Farah; J L Magne; H Guidicelli
Journal:  J Vasc Surg       Date:  2000-11       Impact factor: 4.268

Review 5.  Ruptured popliteal artery aneurysm. An insidious complication.

Authors:  R B Sie; I Dawson; J M van Baalen; L J Schultze Kool; J H van Bockel
Journal:  Eur J Vasc Endovasc Surg       Date:  1997-05       Impact factor: 7.069

6.  Common peroneal nerve compression by a popliteal venous aneurysm.

Authors:  Seong Ho Jang; Honggi Lee; Seung Hoon Han
Journal:  Am J Phys Med Rehabil       Date:  2009-11       Impact factor: 2.159

7.  Common peroneal nerve palsy from an untreated popliteal pseudoaneurysm after penetrating injury.

Authors:  Salim Ersozlu; Mehmet Ozulku; Erkan Yildirim; Reha Tandogan
Journal:  J Vasc Surg       Date:  2007-02       Impact factor: 4.268

8.  Asymptomatic popliteal aneurysm: elective operation versus conservative follow-up.

Authors:  I Dawson; R Sie; J M van Baalen; J H van Bockel
Journal:  Br J Surg       Date:  1994-10       Impact factor: 6.939

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.